Posted on 22nd Nov 2024, by Admin
Head and neck cancer (HNC) includes cancers of the oral cavity, pharynx, larynx, salivary glands, and nasal cavity. According to GLOBOCAN 2022, head and neck cancers accounted for approximately 1.1 million new cases and over 500,000 deaths globally, highlighting their significant health burden (1). Risk factors such as tobacco and alcohol use, human papillomavirus (HPV) infection, and environmental carcinogen exposure are major contributors. Despite advances in treatment, late-stage diagnosis remains common, underlining the critical need for awareness and early detection to improve survival and outcomes.
India bears a disproportionate burden of head and neck cancers, accounting for over 30% of the global cases (3). Tobacco use in various forms (smoking, chewing, betel quid consumption), combined with poor oral hygiene and delayed healthcare access, drives the high incidence of oral cancers. Alarmingly, a majority of Indian patients are diagnosed at advanced stages, reducing survival rates and quality of life. Government initiatives, public health campaigns, and routine screenings are vital for reducing this burden.
Early detection of head and neck cancers significantly improves survival rates. For localized oral cancers, the 5-year survival rate exceeds 80%, but it drops to less than 30% for late-stage diagnoses (2,4). Early intervention often requires less aggressive treatment, preserving vital functions like speech and swallowing, thereby improving quality of life.
Awareness of warning signs like persistent ulcers, voice changes, or unexplained neck lumps can save lives. High-risk individuals, especially tobacco and alcohol users, should seek regular screenings and medical advice. Public awareness campaigns and timely interventions are crucial to reducing the global and national burden of head and neck cancers.